BioSpace News Archive

Leader in prevention provides innovative insight on the enterprise value of preventive health

SaVida Health, a leader in outpatient, medication-assisted treatment for opioid and alcohol addiction, is pleased to announce the opening of its center in Woodbridge, Virginia.

The HonorHealth vice president of research and a retired executive at W.L. Gore & Associates, Inc. have assumed new leadership roles with a statewide committee charged with advancing the biosciences in Arizona.

The Nemours Children’s Health System Board of Directors today announced the election of Robert G. Riney as its chair, effective immediately.

Kewaunee Scientific Corporation announced that the Company plans to release its third quarter fiscal year 2019 financial results on Tuesday, February 26, 2019 after the close of trading.

Interim data show vaccination with mRNA-1653 boosted serum neutralization titers against hMPV and PIV3 at all dose levels tested and was generally well tolerated

Conference Call Scheduled for Tuesday, February 26, 2019 at 4:30pm ET

Crucial Data Solutions announces the latest version release of Clinical Studio, which includes IWRS to truly unify randomization and trial supply management in the clinical trial management process

WuXi Biologics (“WuXi Bio”) (2269.HK), development and manufacturing, and Amicus Therapeutics (“Amicus”) (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases, announced that the companies have entered into an exclusive commercial manufacturing partnership for Amicus’ Pompe biologic ATB200.

Life Spine announced that it will be showcasing their full line of micro-invasive expandable technologies in multiple upcoming events this year.